FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
1-Year Return
57.87%
This Quarter Return
+5.86%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$21.5B
AUM Growth
-$647M
(-2.9%)
Cap. Flow
-$1.41B
Cap. Flow
% of AUM
-6.54%
Top 10 Holdings %
Top 10 Hldgs %
38.78%
Holding
614
New
58
Increased
200
Reduced
215
Closed
65
Top Buys
| 1 |
Salesforce
CRM
|
$165M |
| 2 |
Microsoft
MSFT
|
$164M |
| 3 |
SBA Communications
SBAC
|
$134M |
| 4 |
RHT
Red Hat Inc
RHT
|
$129M |
| 5 |
Boeing
BA
|
$125M |
Top Sells
| 1 |
Broadcom
AVGO
|
$496M |
| 2 |
Apple
AAPL
|
$253M |
| 3 |
Amazon
AMZN
|
$181M |
| 4 |
Crown Castle
CCI
|
$130M |
| 5 |
Microchip Technology
MCHP
|
$129M |
Sector Composition
| 1 | Technology | 25.61% |
| 2 | Consumer Discretionary | 16.32% |
| 3 | Healthcare | 15.75% |
| 4 | Communication Services | 12.15% |
| 5 | Financials | 11.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
Peapack-Gladstone Financial
PGC
$510M
| $142K | ﹤0.01% |
4,252
| – | – |
|
|
XENT
402
DELISTED
Intersect ENT, Inc
XENT
| $118K | ﹤0.01% |
+3,000
| New | +$118K |
|
403
CytomX Therapeutics
CTMX
$376M
| $114K | ﹤0.01% |
+4,000
| New | +$114K |
|
|
CBIO
404
Crescent Biopharma, Inc. Common Stock
CBIO
$198M
| $114K | ﹤0.01% |
70
+50
| +250% | +$81.4K |
|
405
Estee Lauder
EL
$32.1B
| $109K | ﹤0.01% |
729
-150
| -17% | -$22.4K |
|
406
Nektar Therapeutics
NKTR
$764M
| $106K | ﹤0.01% |
+67
| New | +$106K |
|
407
Tandem Diabetes Care
TNDM
$850M
| $99K | ﹤0.01% |
+20,000
| New | +$99K |
|
|
CALA
408
DELISTED
Calithera Biosciences, Inc
CALA
| $88K | ﹤0.01% |
700
+200
| +40% | +$25.1K |
|
|
DERM
409
DELISTED
Dermira, Inc.
DERM
| $88K | ﹤0.01% |
+11,000
| New | +$88K |
|
410
eBay
EBAY
$42.3B
| $84K | ﹤0.01% |
2,090
-276
| -12% | -$11.1K |
|
411
ASML
ASML
$307B
| $83K | ﹤0.01% |
420
-8,285
| -95% | -$1.64M |
|
412
VF Corp
VFC
$5.86B
| $78K | ﹤0.01% |
1,124
+740
| +193% | +$51.4K |
|
413
Verisk Analytics
VRSK
$37.8B
| $78K | ﹤0.01% |
749
| – | – |
|
414
Arista Networks
ANET
$180B
| $77K | ﹤0.01% |
4,816
+688
| +17% | +$11K |
|
|
RARX
415
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $74K | ﹤0.01% |
14,000
-3,000
| -18% | -$15.9K |
|
416
TransUnion
TRU
$17.5B
| $73K | ﹤0.01% |
1,289
+576
| +81% | +$32.6K |
|
417
Marriott International Class A Common Stock
MAR
$71.9B
| $72K | ﹤0.01% |
527
+428
| +432% | +$58.5K |
|
418
L3Harris
LHX
$51B
| $71K | ﹤0.01% |
439
+262
| +148% | +$42.4K |
|
419
IDEX
IEX
$12.4B
| $69K | ﹤0.01% |
482
+291
| +152% | +$41.7K |
|
420
SEI Investments
SEIC
$10.8B
| $69K | ﹤0.01% |
919
+547
| +147% | +$41.1K |
|
421
Target
TGT
$42.3B
| $69K | ﹤0.01% |
1,001
+132
| +15% | +$9.1K |
|
|
MRNS
422
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $69K | ﹤0.01% |
+4,500
| New | +$69K |
|
423
Amphenol
APH
$135B
| $68K | ﹤0.01% |
3,144
-44
| -1% | -$952 |
|
|
AKAO
424
DELISTED
Achaogen, Inc.
AKAO
| $65K | ﹤0.01% |
+5,000
| New | +$65K |
|
|
ESRX
425
DELISTED
Express Scripts Holding Company
ESRX
| $60K | ﹤0.01% |
868
| – | – |
|